US Pharma MarketingSophia Genetics, Memorial Sloan Kettering sign strategic collab for AI-powered precision oncology hub
Sophia Genetics, Memorial Sloan Kettering sign strategic collab for AI-powered precision oncology hub is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The goal of the partnership is to build a precision medicine hub for cancer patients around the globe using MSK’s clinical data and Sophia Genetics’ AI platform.
Source: Fierce Healthcare